Home LiteratureArticle Details
PMID: 21085605 Published · epublish English Journal Article Research Support, N.I.H., Extramural

T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding.

PloS one ·Vol. 5 ·No. 11 ·2010-11-11 ·Pages e13951

Wang Y, Li J, Tang L, Wang Y, Charnigo R, de Villiers W, Eckhardt E

Abstract

Obesity is associated with inflammation of visceral adipose tissues, which increases the risk for insulin resistance. Animal models suggest that T-lymphocyte infiltration is an important early step, although it is unclear why these cells are attracted. We have recently demonstrated that dietary triglycerides, major components of high fat diets, promote intestinal absorption of a protein antigen (ovalbumin, "OVA"). The antigen was partly transported on chylomicrons, which are prominently cleared in adipose tissues. We hypothesized that intestinally absorbed gut antigens may cause T-lymphocyte associated inflammation in adipose tissue. Triglyceride absorption promoted intestinal absorption of OVA into adipose tissue, in a chylomicron-dependent manner. Absorption tended to be higher in mesenteric than subcutaneous adipose tissue, and was lowest in gonadal tissue. OVA immunoreactivity was detected in stromal vascular cells, including endothelial cells. In OVA-sensitized mice, OVA feeding caused marked accumulation of CD3+ and osteopontin+ cells in mesenteric adipose tissue. The accumulating T-lymphocytes were mainly CD4+. As expected, high-fat (60% kCal) diets promoted mesenteric adipose tissue inflammation compared to low-fat diets (10% Kcal), as reflected by increased expression of osteopontin and interferon-gamma. Immune responses to dietary OVA further increased diet-induced osteopontin and interferon-gamma expression in mesenteric adipose. Inflammatory gene expression in subcutaneous tissue did not respond significantly to OVA or dietary fat content. Lastly, whereas OVA responses did not significantly affect bodyweight or adiposity, they significantly impaired glucose tolerance. Our results suggest that loss or lack of immunological tolerance to intestinally absorbed T-lymphocyte antigens can contribute to mesenteric adipose tissue inflammation and defective glucose metabolism during high-fat dieting.

MeSH Terms
Adipose Tissue/immunology,metabolism,pathology Animals CD3 Complex/metabolism Dietary Fats/administration & dosage Flow Cytometry Forkhead Transcription Factors/genetics,metabolism Gene Expression Glucose Intolerance/immunology,metabolism,pathology Immunohistochemistry Inflammation/genetics,immunology,metabolism Intestinal Absorption Intestinal Mucosa/metabolism Iodine Radioisotopes/metabolism,pharmacokinetics Male Mice Mice, Inbred BALB C Mice, Inbred C57BL Osteopontin/metabolism Ovalbumin/immunology,metabolism,pharmacokinetics Reverse Transcriptase Polymerase Chain Reaction T-Lymphocytes/immunology,metabolism
Chemicals
CD3 Complex Dietary Fats Forkhead Transcription Factors Foxp3 protein, mouse Iodine Radioisotopes Osteopontin Ovalbumin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Wang Yuehui
Graduate Center for Nutritional Sciences and Internal Medicine Department, University of Kentucky, Lexington, Kentucky, United States of America.
Li Jianing
Tang Lihua
Wang Yu
Charnigo Richard
de Villiers Willem
Eckhardt Erik
References (33)
33 references, click to expand
  1. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.
    Nat Med. 2009 Aug;15(8):930-9 PMID: 19633656
  2. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.
    Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1304-10 PMID: 18420999
  3. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.
    PLoS One. 2010 Aug 16;5(8):e12191 PMID: 20808947
  4. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
    J Clin Invest. 2003 Dec;112(12):1821-30 PMID: 14679177
  5. Obesity and the metabolic syndrome in children and adolescents.
    N Engl J Med. 2004 Jun 3;350(23):2362-74 PMID: 15175438
  6. Oral tolerance and its relation to food hypersensitivities.
    J Allergy Clin Immunol. 2005 Jan;115(1):3-12; quiz 13 PMID: 15637539
  7. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.
    Nat Med. 2009 Aug;15(8):940-5 PMID: 19633655
  8. Metabolic endotoxemia initiates obesity and insulin resistance.
    Diabetes. 2007 Jul;56(7):1761-72 PMID: 17456850
  9. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
    Circulation. 1983 May;67(5):968-77 PMID: 6219830
  10. Normalization of obesity-associated insulin resistance through immunotherapy.
    Nat Med. 2009 Aug;15(8):921-9 PMID: 19633657
  11. Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans.
    J Lipid Res. 1997 Nov;38(11):2335-43 PMID: 9392431
  12. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.
    J Clin Invest. 2007 Oct;117(10):2877-88 PMID: 17823662
  13. Preferential uptake of dietary Fatty acids in adipose tissue and muscle in the postprandial period.
    Diabetes. 2007 Jan;56(1):168-76 PMID: 17192479
  14. Inflammation and metabolic disorders.
    Nature. 2006 Dec 14;444(7121):860-7 PMID: 17167474
  15. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.
    Science. 2010 Apr 9;328(5975):228-31 PMID: 20203013
  16. Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat.
    Am J Physiol. 1981 Dec;241(6):G487-97 PMID: 7325240
  17. An obesity-associated gut microbiome with increased capacity for energy harvest.
    Nature. 2006 Dec 21;444(7122):1027-31 PMID: 17183312
  18. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases.
    Nat Clin Pract Gastroenterol Hepatol. 2005 Feb;2(2):103-11 PMID: 16265128
  19. Chylomicrons promote intestinal absorption of lipopolysaccharides.
    J Lipid Res. 2009 Jan;50(1):90-7 PMID: 18815435
  20. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.
    Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84 PMID: 17210919
  21. Chylomicrons promote intestinal absorption and systemic dissemination of dietary antigen (ovalbumin) in mice.
    PLoS One. 2009 Dec 24;4(12):e8442 PMID: 20041190
  22. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease.
    Gut. 2005 Jun;54(6):789-96 PMID: 15888786
  23. Abdominal obesity and metabolic syndrome.
    Nature. 2006 Dec 14;444(7121):881-7 PMID: 17167477
  24. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.
    Nat Med. 2009 Aug;15(8):914-20 PMID: 19633658
  25. TLR4 links innate immunity and fatty acid-induced insulin resistance.
    J Clin Invest. 2006 Nov;116(11):3015-25 PMID: 17053832
  26. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation.
    Am J Clin Nutr. 2007 Nov;86(5):1286-92 PMID: 17991637
  27. Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion.
    Am J Physiol. 1991 Sep;261(3 Pt 1):G384-91 PMID: 1887887
  28. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism.
    FASEB J. 2010 Dec;24(12):4948-59 PMID: 20724524
  29. Obesity is associated with macrophage accumulation in adipose tissue.
    J Clin Invest. 2003 Dec;112(12):1796-808 PMID: 14679176
  30. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.
    Diabetes. 2007 Apr;56(4):1010-3 PMID: 17287468
  31. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity.
    Circ Res. 2008 Aug 29;103(5):467-76 PMID: 18658050
  32. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.
    Endocrinology. 2004 May;145(5):2273-82 PMID: 14726444
  33. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages.
    Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):84-91 PMID: 17082484
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2010-11-11
Epub
2010-00-11
Pages
e13951
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC2978720
Subset
IM
Grants
NCRR NIH HHS · 1P20RR021954-01A2 · United States
NIAID NIH HHS · R21 AI088605 · United States
NCRR NIH HHS · P20 RR021954-04 · United States
NIAID NIH HHS · 1R21AI088605-01 · United States
NCRR NIH HHS · P20 RR021954 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]